This suggests that, inside the nucleus of breast tumor cells, Vav1 may compete with the classical nuclear activity of ERα, a ligand-dependent transcription factor known to play a crucial role in breast cancer development and/or progression [20]. The gene discussed is ESR1; the disease is breast neoplasm.